SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-24-037441
Filing Date
2024-03-21
Accepted
2024-03-21 19:52:32
Documents
1
Period of Report
2024-03-19

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm249503-7_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm249503-7_4seq1.xml 4 4261
  Complete submission text file 0001104659-24-037441.txt   5818
Mailing Address C/O RXSIGHT, INC. 100 COLUMBIA ALISO VIEJO CA 92656
Business Address
Thunen Shelley B (Reporting) CIK: 0001297491 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40021 | Film No.: 24772774

Mailing Address 5 PARK PLAZA SUITE 1750 IRVINE CA 92614
Business Address 5 PARK PLAZA SUITE 1750 IRVINE CA 92614 (949) 354-6499
AEON Biopharma, Inc. (Issuer) CIK: 0001837607 (see all company filings)

IRS No.: 853940478 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)